Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration

por Luo, Baohong, Zhan, Yikang, Luo, Minqi, Dong, Huimin, Liu, Jun, Lin, Yingtong, Zhang, Junsong, Wang, Guanwen, Verhoeyen, Els, Zhang, Yiwen, Zhang, Hui
Publicado 2020

Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses

por Qiao, Yidan, Zhan, Yikang, Zhang, Yongli, Deng, Jieyi, Chen, Achun, Liu, Bingfeng, Zhang, Yiwen, Pan, Ting, Zhang, Wangjian, Zhang, Hui, He, Xin
Publicado 2022

Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses

por Ma, Xiancai, Zou, Fan, Yu, Fei, Li, Rong, Yuan, Yaochang, Zhang, Yiwen, Zhang, Xiantao, Deng, Jieyi, Chen, Tao, Song, Zheng, Qiao, Yidan, Zhan, Yikang, Liu, Jun, Zhang, Junsong, Zhang, Xu, Peng, Zhilin, Li, Yuzhuang, Lin, Yingtong, Liang, Liting, Wang, Guanwen, Chen, Yingshi, Chen, Qier, Pan, Ting, He, Xin, Zhang, Hui
Publicado 2020